Patient-reported outcome measures in a pharmacokinetic study with sunitinib, a prospective cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient-reported outcome measures in a pharmacokinetic study with sunitinib, a prospective cohort study

Published:2018-02-21 Issue:8 Volume:26 Page:2641-2650
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Koldenhof J. J.,Lankheet N. A. G.,Steeghs N.,Teunissen S. C. C. M.,Witteveen P. O.

Funder

University Medical Center Utrecht

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/article/10.1007/s00520-018-4075-7/fulltext.html

Reference33 articles.

1. Tsimberidou A-M, Iskander NG, Hong DS, Wheler JJ, Falchook GS, Fu S et al (2012) Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative. Clin Cancer Res United States 18(22):6373–6383

2. Klümpen HJ, Samer CF, Mathijssen RHJ, Schellens JHM, Gurney H (2011) Moving towards dose individualization of tyrosine kinase inhibitors. Cancer Treat Rev 37(4):251–260

3. Postel-Vinay S, Soria JC (2015) Phase I trials in oncology: a new era has started. Ann Oncol 26(1):7–9

4. Yu H, Steeghs N, Nijenhuis CM, Schellens JHM, Beijnen JH, Huitema ADR (2014) Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targets. Clin Pharmacokinet New Zealand 53(4):305–325

5. CTCAE 4.03. CTCAE 4.03 [Internet]. 2010 [cited 2017 Mar 1]. Available from: http://www.hrc.govt.nz/sites/default/files/CTCAE manual - DMCC.pdf

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-Reported Outcomes During Checkpoint Inhibition: Insight into Symptom Burden in Daily Clinical Practice;Journal of Pain and Symptom Management;2022-06

2. Validation of the Dutch version of the Edmonton Symptom Assessment System;Cancer Medicine;2020-07-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3